Single dose treatment for malariaCreated by:
A new drug that stops the malaria parasite in its tracks, and could be delivered in a single dose, has researchers excited about treatment prospects for the disease.
The newly discovered synthetic compound attacks the malaria parasite at multiple stages of its life cycle. It promises an effective new mode for drug delivery that could evade the bug’s emergent resistance.
Research conducted by an international team and published in the journal nature, showed that a single dose of the compound (called DDD107498) not only cured malarial infection caused by the Plasmodum falciparum strain of parasite in mouse models, it also prevented them from acquiring the infection.
Malaria kills more than half a million people each year and infects between one and two million, predominantly in sub-Saharan Africa.
Now ther compoind Is in the hands of Meeck INC.